DENOCI 60 MG INJECTION LIQUID

Form: Injection

Pack Size: 60mg in 1ml single u

Marketed by: CIPLA LTD (CANCER CARE)

MRP: ₹17015.62

Denoci 60mg by Cipla (denosumab 60 mg, 1 prefilled syringe of 1 ml) is a RANKL-inhibiting monoclonal antibody (bone-targeted therapy) listed under Cancer Care (Oncology) on WholesaleChemist for distributors, hospital pharmacies and retail chemists. Prescribed by oncologists, endocrinologists and orthopaedic specialists for osteoporosis in postmenopausal women and in men at high risk of fracture, and bone loss caused by hormone therapy for prostate or breast cancer. Schedule H: dispense only against a valid prescription. Counselling point: correct calcium and vitamin D first; dental review because of osteonecrosis-of-the-jaw risk. Cold-chain item: store at 2-8°C, do not freeze.

Available at wholesale price for chemists, retailers and distributors on WholesaleChemist.